Geneviéve B. Berger

Geneviéve B. Berger currently works at Kerry Group Plc, as Independent Non-Executive Director from 2023 and Dassault Systèmes SE, as Independent Non-Executive Director from 2023.
Dr. Berger also formerly worked at Centre National de la Recherche Scientifique, as Chief Executive Officer in 2003, AstraZeneca PLC, as Independent Non-Executive Director from 2012 to 2021, Smith & Nephew plc, as Independent Non-Executive Director from 2010 to 2012, Air Liquide Tunisie SA, as Independent Director, Air Liquide SA, as Independent Director from 2015 to 2023, Université Pierre et Marie Curie, as Director-Mixed Laboratory from 1991 to 2000, Merz Pharma GmbH & Co. KGaA, as Non-Executive Director, France Ministry of National Education, Higher Educ & Research, as Technology Director from 1998 to 2000, École normale supérieure Paris-Saclay, as Director in 2003, Institut Français de Recherche pour l'Exploitation de la Mer, as Director, Unilever Plc, as Chief Scientific Officer from 2013 to 2014, Unilever NV, as Chief Research & Development Officer from 2008 to 2013, Assistance Publique des Hôpitaux de Paris SA, as Professor in 2008, Université Paris 1 Panthéon-Sorbonne, as Professor, Unilever France SAS, as Chief Research & Development Officer from 2008 to 2014, Religieuses Hospitalières de Saint-Joseph, as Head-Biosphysics & Nuclear Medicine in 2000, Firmenich International SA, as Chief Science Officer, Groupe hospitalier Pitié-Salpêtrière, as Professor from 2003 to 2008, University Hospitals Pitié Salpêtrière-Charles Foix, as Chief Science, Research & Development Officer from 2008 to 2014, and Firmenich SA, as Chief Research Officer from 2015 to 2021.
Dr. Berger received her doctorate degree in 1981 from Université Pierre et Marie Curie, undergraduate degree in 1978 from École normale supérieure Paris-Saclay, doctorate degree in 1985 from Université de Paris 5 René Descartes, and doctorate degree in 1989 from Université de Paris 5 René Descartes.